Cyteir Therapeutics Secures $80 Million in Series C Financing to Advance Clinical Trials of Lead RAD51 Program

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2MQTwpQ
via IFTTT